Redensity 2 Filler for Tear Trough Treatments in London

Volume loss beneath the eyes is one of the earliest and most visible signs of facial ageing. As the periorbital fat pads descend and dermal support diminishes, hollow tear troughs form — casting shadows that contribute to the appearance of dark circles and persistent fatigue.

Teosyal Redensity 2 is a hyaluronic acid-based filler developed specifically for this delicate eye area. At our London clinic, tear trough filler treatment using professional Redensity 2 is planned individually, with technique and volume determined by anatomy, skin quality, and the degree of correction required.

Volume loss beneath the eyes is one of the earliest and most visible signs of facial ageing. As the periorbital fat pads descend and dermal support diminishes, hollow tear troughs form — casting shadows that contribute to the appearance of dark circles and persistent fatigue. Teosyal Redensity 2 is a hyaluronic acid-based filler developed specifically for this delicate eye area. At our London clinic, tear trough filler treatment using professional Redensity 2 is planned individually, with technique and volume determined by anatomy, skin quality, and the degree of correction required.

Consultation and pricing

Treatment suitability, the personalised plan, and final cost are confirmed after consultation and clinical assessment. Pricing reflects individual anatomy, product volume, treatment scope, number of areas, and clinical complexity.

The figures below represent general market guidance only, based on publicly advertised prices reviewed in June 2026 across 10 London clinics. These are not our clinic’s prices and may not reflect consultation fees, product volume differences, promotional pricing, technique variations, or individual treatment planning.

London market guide — Redensity 2 Tear Trough Filler

  • Tear trough filler (both eyes, 1ml): about £450–£650
  • Single under-eye area: about £350–£500
  • Combined with mid-face filler: about £650–£1,100
  • Maintenance top-up session: about £300–£500

Before and After Redensity 2 Filler Treatment

Following tear trough filler, the under-eye hollow typically appears softened, with reduced shadowing and a smoother transition between the lower lid and cheek. Initial improvements are often visible within days, with final results settling over one to three weeks.

As dermal integration progresses, the under-eye area may appear more refreshed and better rested. Patients commonly describe a natural improvement in overall facial appearance, with dark circles and hollows looking less pronounced as the filler distributes evenly within the tissue.

Visible improvements patients commonly report:

What is Redensity 2 Filler?

Teosyal Puresense Redensity 2 is an advanced dermal filler developed by Teoxane Laboratories, formulated specifically for the periorbital region. It combines cross-linked and non-cross-linked hyaluronic acid with hyaluronic acid and essential nutrients, including amino acids, to support both volume correction and skin quality in the under-eye area.

Unlike standard dermal filler products used elsewhere on the face, Teosyal Redensity 2 is low-hydrophilic — meaning it is less likely to attract excess water into the treated tissue. This characteristic makes it particularly suitable for the delicate eye area, where excessive hydration can contribute to puffiness or irregularity.

The formulation also contains lidocaine, which may help improve comfort during the procedure. As a hyaluronic acid filler, Redensity II is reversible, which is a relevant consideration for treatment in a high-risk anatomical zone.

Key characteristics of Teosyal Puresense Redensity 2:

  • Hyaluronic acid-based filler designed specifically for the tear trough area
  • Combines cross-linked and non-cross-linked HA for soft, integrative placement
  • Low-hydrophilic formulation intended to reduce the risk of post-treatment puffiness
  • Contains lidocaine to support comfort during injection
  • Developed by Teoxane Laboratories as part of the Teosyal range
  • Reversible with hyaluronidase, where clinically required

The Redensity 2 Filler Process: Step by Step

01

Initial Consultation

A face-to-face consultation explores your under-eye concerns, aesthetic goals, relevant medical history, and clinical suitability for tear trough filler. Where prescription products are required, Dr. Ivan provides this assessment.

02

Clinical Assessment and Treatment Planning

The tear trough area and surrounding periorbital tissue are evaluated for hollowing, skin thickness, fat pad position, and prior treatment history. A personalised treatment plan is prepared based on clinical findings.

03

Pre-Treatment Preparation

The skin is cleansed thoroughly. Numbing cream may be applied to the under-eye area in advance to support comfort during the procedure, where clinically appropriate.

04

Treatment Delivery

Teosyal Redensity 2 is administered via careful injection into the tear trough area using a fine needle or micro-cannula, depending on anatomy and clinical preference. Sessions typically take between 20 and 40 minutes.

05

Aftercare and Recovery Guidance

Specific aftercare instructions are provided following each session to support recovery, minimise the risk of bruising, and optimise outcomes in the days following treatment.

Procedure time: 20–40 minutes

Recovery: Minimal downtime is typical. Mild swelling, tenderness, or bruising around the eyes may occur and generally resolves within 5 to 10 days following treatment.

Benefits of Redensity 2 Filler

For individuals experiencing tear troughs and dark circles, hollow under-eye contours, or loss of volume at the lid-cheek junction, Teosyal Redensity 2 filler may help improve the appearance of the periorbital region in a way that complements overall facial proportions. Its low-hydrophilic properties and soft consistency are considered well-suited to the delicate eye area.

Results from tear trough filler treatment tend to develop naturally, with improvements in shadow reduction, contour, and skin hydration becoming more apparent as the product integrates over the first one to two weeks. The approach is designed to improve the appearance of dark circles and hollows while maintaining a natural, unaltered look in the surrounding tissue.

The treatment is compatible with other aesthetic procedures and may be incorporated into broader facial rejuvenation planning where clinically appropriate. Many patients seeking natural aesthetic outcomes and a refreshed appearance without surgical intervention find that targeted under-eye treatment can meaningfully enhance their overall look.

Key benefits of Redensity 2 tear trough filler:

Redensity 2 Filler Treatment Options

Option One: Targeted Tear Trough Treatment

A focused approach for patients with mild to moderate under-eye hollowing and dark circles. Teosyal Redensity 2 is placed precisely within the tear trough area using a technique selected for individual anatomy. Suitable for patients seeking a subtle improvement with natural-looking results and minimal intervention.

Option Two: Bilateral Under-Eye and Mid-Face Correction

A more comprehensive protocol addressing volume loss across both the tear trough and the adjacent mid-face transition zone. This approach may be appropriate where the hollowing reflects broader structural change, and where supporting the cheek framework alongside the under-eye area may help improve overall contour and balance.

Option Three: Combined Filler and Skin Quality Protocol

An integrated approach pairing Redensity 2 tear trough filler with a complementary skin quality treatment, such as Redensity 1 or skin boosters, to address both structural hollowing and dermal texture around the eyes. This option may be appropriate for patients with additional concerns relating to skin hydration, fine lines around the eyes, or lines and wrinkles in the periorbital zone.

Summary of available treatment approaches:

  • Targeted Redensity 2 filler for isolated tear trough hollowing
  • Bilateral under-eye correction for moderate volume loss around the eyes
  • Combined under-eye and mid-face filler for patients with broader structural concerns
  • Integrated filler and skin quality protocol for those with additional periorbital skin concerns
  • Course-based planning for patients requiring reassessment and maintenance following initial treatment

Why Choose Us?

Angelika brings over eight years of international medical experience to each treatment, applying advanced techniques within a structured, safety-conscious approach to the delicate eye area. Her clinical method prioritises precise placement and natural aesthetic outcomes over volume-led correction.

Tear trough filler requires particular care in product selection, injection technique, and individual anatomy assessment. Every treatment plan is built from a thorough clinical evaluation rather than a fixed protocol.

Where prescription-only products are clinically required, Dr. Ivan provides the necessary face-to-face consultation and prescribing through a structured and compliant pathway. This ensures that patients receive both qualified aesthetic delivery and appropriate medical oversight for treatments in high-risk anatomical areas.

The clinic is located in central London, providing consistent access for follow-up, review, and any aftercare required in the weeks following treatment.

What distinguishes our approach:

  • Over 8 years of international medical experience, informing clinical technique in the periorbital region
  • Advanced aesthetic practice aligned with UK certification, insurance, and patient safety standards
  • GMC-registered prescribing support from Dr. Ivan, where clinically required
  • Personalised treatment planning confirmed through thorough clinical assessment of anatomy and medical history
  • Evidence-based injectable protocols, not trend-led or interchangeable approaches
  • Central London clinic environment with consistent professional standards and post-treatment review

Disclaimer: Angelika is an aesthetic practitioner, not a medical doctor. Where prescription-only products are clinically appropriate, face-to-face consultation and prescribing are provided by GMC-registered prescriber Dr. Ivan. This treatment is available to patients aged 18 and over.

Frequently Asked Questions

Results from Teosyal Redensity 2 in the tear trough area vary between individuals and depend on factors including age, skin condition, lifestyle, and volume placed. Many patients find improvements in under-eye contour and dark circles may persist for approximately 12 to 18 months, though individual outcomes differ. Maintenance sessions can help sustain the appearance achieved, and timing is best discussed during your follow-up assessment.

The tear trough is one of the most technically demanding areas in facial aesthetics, and every treatment carries potential risks and considerations. These may include bruising, swelling, asymmetry, lumpiness, the Tyndall effect — a bluish discolouration caused by superficial placement — and, in rare cases, vascular complications. Treatment suitability and individual risk profile are assessed carefully during consultation, and hyaluronidase is available to dissolve the filler if required.

Volume requirements depend on individual anatomy, the depth of the hollow, and the degree of mid-face volume loss present. Many patients require approximately 0.5 to 1ml across both eyes for initial treatment, though some anatomies may warrant a staged approach. A personalised treatment plan confirming volume and session structure is confirmed during clinical assessment rather than in advance of consultation.

Teosyal Puresense Redensity 2 contains lidocaine within the formulation, which may support comfort during the injection procedure. Numbing cream may also be applied to the under-eye area beforehand. Most patients describe mild pressure or brief stinging at the injection site. Discomfort levels vary depending on individual sensitivity, technique used, and the extent of treatment required. Your practitioner will adjust the approach to support comfort throughout.

Tear trough filler is generally associated with minimal downtime, though the periorbital region is particularly prone to bruising and swelling due to the density of the vascular network in this area. Mild swelling, tenderness, or bruising may be present for several days following treatment and can take up to 10 days to fully resolve. Aftercare guidance is provided at the end of each session to help minimise the risk of bruising and support recovery.

Tear trough filler may be appropriate for adults experiencing hollow under-eye contours, dark circles caused by structural shadowing, or volume loss at the lid-cheek junction. Suitability depends on individual anatomy, skin thickness, medical history, and the degree of hollowing present. Patients with very thin or lax skin, significant periorbital fat prolapse, or certain health conditions may not be suitable candidates. Assessment is carried out during a thorough face-to-face consultation.

Initial improvement in the under-eye contour is often visible shortly after treatment, though some swelling may temporarily affect the appearance in the first few days. Final results generally become apparent once any post-treatment swelling has resolved, typically within one to two weeks. The quality of integration and the overall appearance of the tear trough area continue to settle during this period, and a review appointment is recommended to assess the outcome.

Teosyal Redensity 2 filler is frequently considered alongside complementary treatments such as Redensity 1, skin boosters for hydration and skin quality around the eyes, or mid-face filler to address broader structural concerns. The sequencing and suitability of any combined approach are assessed during consultation and planned carefully to suit individual anatomy and treatment goals. Book your consultation to discuss the most appropriate combination strategy for your concerns.